Cecha
Breathing difficulty
Nazwa kliniczna: Dyspnea
Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.
Podsumowanie
- Znana także jako
- Difficult to breathe, Difficulty breathing, Panting, Shortness of breath, Trouble breathing, Abnormal breathing, Dyspnoea
- Układ organizmu
- Abnormality of the respiratory system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Breathing difficulty, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test236 genów powiązanych z Breathing difficulty
Zmiany w tych genach powodują rzadkie choroby, w których występuje Breathing difficulty. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| APOA1apolipoprotein A1 | Zawsze | W 1 chorobie |
| CAPNS1calpain small subunit 1 | Zawsze | W 1 chorobie |
| CSF2RBcolony stimulating factor 2 receptor subunit beta | Zawsze | W 1 chorobie |
| DNAJB4DnaJ heat shock protein family (Hsp40) member B4 | Zawsze | W 1 chorobie |
| DSG2desmoglein 2 | Zawsze | W 1 chorobie |
| EIF2AK4eukaryotic translation initiation factor 2 alpha kinase 4 | Zawsze | W 2 chorobach |
| EMDemerin | Zawsze | W 1 chorobie |
| ENGendoglin | Zawsze | W 1 chorobie |
| FDX2ferredoxin 2 | Zawsze | W 1 chorobie |
| FZR1fizzy and cell division cycle 20 related 1 | Zawsze | W 1 chorobie |
| GAAalpha glucosidase | Zawsze | W 1 chorobie |
| JPH2junctophilin 2 | Zawsze | W 1 chorobie |
| LDB3LIM domain binding 3 | Zawsze | W 1 chorobie |
| MYZAPmyocardial zonula adherens protein | Zawsze | W 1 chorobie |
| OPA1OPA1 mitochondrial dynamin like GTPase | Zawsze | W 1 chorobie |
| PIGTphosphatidylinositol glycan anchor biosynthesis class T | Zawsze | W 1 chorobie |
| POT1protection of telomeres 1 | Zawsze | W 1 chorobie |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Zawsze | W 1 chorobie |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Zawsze | W 2 chorobach |
| SCO2synthesis of cytochrome C oxidase 2 | Zawsze | W 1 chorobie |
| SFTPA1surfactant protein A1 | Zawsze | W 1 chorobie |
| SLC25A4solute carrier family 25 member 4 | Zawsze | W 1 chorobie |
| SPINK5serine peptidase inhibitor Kazal type 5 | Zawsze | W 1 chorobie |
| TERTtelomerase reverse transcriptase | Zawsze | W 3 chorobach |
| CAV1caveolin 1 | Bardzo często (80–99%) | W 2 chorobach |
| CCN2cellular communication network factor 2 | Bardzo często (80–99%) | W 1 chorobie |
| CCR6C-C motif chemokine receptor 6 | Bardzo często (80–99%) | W 1 chorobie |
| EPORerythropoietin receptor | Bardzo często (80–99%) | W 1 chorobie |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Bardzo często (80–99%) | W 4 chorobach |
| IRF5interferon regulatory factor 5 | Bardzo często (80–99%) | W 1 chorobie |
| MARS1methionyl-tRNA synthetase 1 | Bardzo często (80–99%) | W 1 chorobie |
| RNU4ATACRNA, U4atac small nuclear | Bardzo często (80–99%) | W 1 chorobie |
| TSC1TSC complex subunit 1 | Bardzo często (80–99%) | W 1 chorobie |
| TSC2TSC complex subunit 2 | Bardzo często (80–99%) | W 1 chorobie |
| UBE3Bubiquitin protein ligase E3B | Bardzo często (80–99%) | W 1 chorobie |
| ABCC9ATP binding cassette subfamily C member 9 | Często (30–79%) | W 1 chorobie |
| ABCG5ATP binding cassette subfamily G member 5 | Często (30–79%) | W 1 chorobie |
| ABCG8ATP binding cassette subfamily G member 8 | Często (30–79%) | W 1 chorobie |
| ANGangiogenin | Często (30–79%) | W 1 chorobie |
| ANXA11annexin A11 | Często (30–79%) | W 1 chorobie |
Pokaż jeszcze 196 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| APOBapolipoprotein B | Często (30–79%) | W 1 chorobie |
| ATRXATRX chromatin remodeler | Często (30–79%) | W 1 chorobie |
| ATXN2ataxin 2 | Często (30–79%) | W 1 chorobie |
| BANF1barrier to autointegration nuclear assembly factor 1 | Często (30–79%) | W 1 chorobie |
| BAP1BRCA1 associated deubiquitinase 1 | Często (30–79%) | W 1 chorobie |
| BMPR2bone morphogenetic protein receptor type 2 | Często (30–79%) | W 1 chorobie |
| BTNL2butyrophilin like 2 | Często (30–79%) | W 2 chorobach |
| CCNFcyclin F | Często (30–79%) | W 1 chorobie |
| CDC45cell division cycle 45 | Często (30–79%) | W 1 chorobie |
| CDC6cell division cycle 6 | Często (30–79%) | W 1 chorobie |
| CDT1chromatin licensing and DNA replication factor 1 | Często (30–79%) | W 1 chorobie |
| CFAP410cilia and flagella associated protein 410 | Często (30–79%) | W 1 chorobie |
| CFTRCF transmembrane conductance regulator | Często (30–79%) | W 1 chorobie |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Często (30–79%) | W 1 chorobie |
| CHMP2Bcharged multivesicular body protein 2B | Często (30–79%) | W 1 chorobie |
| DAOD-amino acid oxidase | Często (30–79%) | W 1 chorobie |
| DCTN1dynactin subunit 1 | Często (30–79%) | W 1 chorobie |
| DNASE1L3deoxyribonuclease 1L3 | Często (30–79%) | W 1 chorobie |
| ELNelastin | Często (30–79%) | W 2 chorobach |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Często (30–79%) | W 1 chorobie |
| FAM20CFAM20C golgi associated secretory pathway kinase | Często (30–79%) | W 1 chorobie |
| FIG4FIG4 phosphoinositide 5-phosphatase | Często (30–79%) | W 1 chorobie |
| FUSFUS RNA binding protein | Często (30–79%) | W 1 chorobie |
| GATA4GATA binding protein 4 | Często (30–79%) | W 2 chorobach |
| GATA5GATA binding protein 5 | Często (30–79%) | W 1 chorobie |
| GATA6GATA binding protein 6 | Często (30–79%) | W 2 chorobach |
| GBA1glucosylceramidase beta 1 | Często (30–79%) | W 2 chorobach |
| GJA5gap junction protein alpha 5 | Często (30–79%) | W 1 chorobie |
| GLE1GLE1 RNA export mediator | Często (30–79%) | W 1 chorobie |
| GLT8D1glycosyltransferase 8 domain containing 1 | Często (30–79%) | W 1 chorobie |
| GMNNgeminin DNA replication inhibitor | Często (30–79%) | W 1 chorobie |
| HBBhemoglobin subunit beta | Często (30–79%) | W 2 chorobach |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Często (30–79%) | W 1 chorobie |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Często (30–79%) | W 1 chorobie |
| KCNA5potassium voltage-gated channel subfamily A member 5 | Często (30–79%) | W 1 chorobie |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Często (30–79%) | W 1 chorobie |
| KCNE2potassium voltage-gated channel subfamily E regulatory subunit 2 | Często (30–79%) | W 1 chorobie |
| KCNJ2potassium inwardly rectifying channel subfamily J member 2 | Często (30–79%) | W 1 chorobie |
| KCNJ3potassium inwardly rectifying channel subfamily J member 3 | Często (30–79%) | W 1 chorobie |
| KCNJ5potassium inwardly rectifying channel subfamily J member 5 | Często (30–79%) | W 1 chorobie |
| KCNJ6potassium inwardly rectifying channel subfamily J member 6 | Często (30–79%) | W 1 chorobie |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Często (30–79%) | W 1 chorobie |
| KLHL24kelch like family member 24 | Często (30–79%) | W 1 chorobie |
| LAMA3laminin subunit alpha 3 | Często (30–79%) | W 1 chorobie |
| LAMB3laminin subunit beta 3 | Często (30–79%) | W 1 chorobie |
| LAMC2laminin subunit gamma 2 | Często (30–79%) | W 1 chorobie |
| LAMP2lysosome associated membrane protein 2 | Często (30–79%) | W 1 chorobie |
| LDLRlow density lipoprotein receptor | Często (30–79%) | W 1 chorobie |
| LDLRAP1low density lipoprotein receptor adaptor protein 1 | Często (30–79%) | W 1 chorobie |
| LRP12LDL receptor related protein 12 | Często (30–79%) | W 1 chorobie |
| MATR3matrin 3 | Często (30–79%) | W 1 chorobie |
| MGME1mitochondrial genome maintenance exonuclease 1 | Często (30–79%) | W 2 chorobach |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Często (30–79%) | W 2 chorobach |
| MYL4myosin light chain 4 | Często (30–79%) | W 1 chorobie |
| NEFHneurofilament heavy chain | Często (30–79%) | W 1 chorobie |
| NEK1NIMA related kinase 1 | Często (30–79%) | W 1 chorobie |
| NKX2-5NK2 homeobox 5 | Często (30–79%) | W 3 chorobach |
| NKX2-6NK2 homeobox 6 | Często (30–79%) | W 1 chorobie |
| NPPAnatriuretic peptide A | Często (30–79%) | W 3 chorobach |
| NUP155nucleoporin 155 | Często (30–79%) | W 1 chorobie |
| OPTNoptineurin | Często (30–79%) | W 1 chorobie |
| ORC1origin recognition complex subunit 1 | Często (30–79%) | W 1 chorobie |
| ORC4origin recognition complex subunit 4 | Często (30–79%) | W 1 chorobie |
| ORC6origin recognition complex subunit 6 | Często (30–79%) | W 2 chorobach |
| PCSK9proprotein convertase subtilisin/kexin type 9 | Często (30–79%) | W 1 chorobie |
| PFN1profilin 1 | Często (30–79%) | W 1 chorobie |
| PGM1phosphoglucomutase 1 | Często (30–79%) | W 1 chorobie |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Często (30–79%) | W 1 chorobie |
| PITX2paired like homeodomain 2 | Często (30–79%) | W 1 chorobie |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Często (30–79%) | W 1 chorobie |
| PRPHperipherin | Często (30–79%) | W 1 chorobie |
| RFC4replication factor C subunit 4 | Często (30–79%) | W 1 chorobie |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Często (30–79%) | W 2 chorobach |
| SCN2Bsodium voltage-gated channel beta subunit 2 | Często (30–79%) | W 1 chorobie |
| SCN3Bsodium voltage-gated channel beta subunit 3 | Często (30–79%) | W 1 chorobie |
| SCN4Bsodium voltage-gated channel beta subunit 4 | Często (30–79%) | W 1 chorobie |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Często (30–79%) | W 4 chorobach |
| SCNN1Asodium channel epithelial 1 subunit alpha | Często (30–79%) | W 1 chorobie |
| SCNN1Bsodium channel epithelial 1 subunit beta | Często (30–79%) | W 1 chorobie |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Często (30–79%) | W 1 chorobie |
| SERPING1serpin family G member 1 | Często (30–79%) | W 1 chorobie |
| SFTPCsurfactant protein C | Często (30–79%) | W 2 chorobach |
| SLC34A2solute carrier family 34 member 2 | Często (30–79%) | W 1 chorobie |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Często (30–79%) | W 1 chorobie |
| SOD1superoxide dismutase 1 | Często (30–79%) | W 1 chorobie |
| SQSTM1sequestosome 1 | Często (30–79%) | W 1 chorobie |
| TAF15TATA-box binding protein associated factor 15 | Często (30–79%) | W 1 chorobie |
| TARDBPTAR DNA binding protein | Często (30–79%) | W 1 chorobie |
| TBK1TANK binding kinase 1 | Często (30–79%) | W 1 chorobie |
| TMEM126Btransmembrane protein 126B | Często (30–79%) | W 1 chorobie |
| TREM2triggering receptor expressed on myeloid cells 2 | Często (30–79%) | W 1 chorobie |
| TRMT5tRNA methyltransferase 5 | Często (30–79%) | W 1 chorobie |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Często (30–79%) | W 1 chorobie |
| TSFMTs translation elongation factor, mitochondrial | Często (30–79%) | W 1 chorobie |
| TTNtitin | Często (30–79%) | W 2 chorobach |
| UBQLN2ubiquilin 2 | Często (30–79%) | W 1 chorobie |
| UNC13Aunc-13 homolog A | Często (30–79%) | W 1 chorobie |
| VAPBVAMP associated protein B and C | Często (30–79%) | W 1 chorobie |
| VCPvalosin containing protein | Często (30–79%) | W 2 chorobach |
| WASWASP actin nucleation promoting factor | Często (30–79%) | W 1 chorobie |
| ACTC1actin alpha cardiac muscle 1 | Czasami (5–29%) | W 2 chorobach |
| AGR2anterior gradient 2, protein disulphide isomerase family member | Czasami (5–29%) | W 1 chorobie |
| ALAS25'-aminolevulinate synthase 2 | Czasami (5–29%) | W 1 chorobie |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Czasami (5–29%) | W 1 chorobie |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Czasami (5–29%) | W 2 chorobach |
| COL1A2collagen type I alpha 2 chain | Czasami (5–29%) | W 1 chorobie |
| COL4A5collagen type IV alpha 5 chain | Czasami (5–29%) | W 1 chorobie |
| COL4A6collagen type IV alpha 6 chain | Czasami (5–29%) | W 1 chorobie |
| COPAcoat protein complex I subunit alpha | Czasami (5–29%) | W 1 chorobie |
| COX7Bcytochrome c oxidase subunit 7B | Czasami (5–29%) | W 1 chorobie |
| DBHdopamine beta-hydroxylase | Czasami (5–29%) | W 1 chorobie |
| DNA2DNA replication helicase/nuclease 2 | Czasami (5–29%) | W 1 chorobie |
| DNAJB6DnaJ heat shock protein family (Hsp40) member B6 | Czasami (5–29%) | W 1 chorobie |
| DSC2desmocollin 2 | Czasami (5–29%) | W 1 chorobie |
| FBP1fructose-bisphosphatase 1 | Czasami (5–29%) | W 2 chorobach |
| FLNCfilamin C | Czasami (5–29%) | W 1 chorobie |
| GLAgalactosidase alpha | Czasami (5–29%) | W 1 chorobie |
| GNASGNAS complex locus | Czasami (5–29%) | W 3 chorobach |
| HCCSholocytochrome c synthase | Czasami (5–29%) | W 1 chorobie |
| HLA-Bmajor histocompatibility complex, class I, B | Czasami (5–29%) | W 2 chorobach |
| IKZF1IKAROS family zinc finger 1 | Czasami (5–29%) | W 1 chorobie |
| IL12Binterleukin 12B | Czasami (5–29%) | W 1 chorobie |
| IPO8importin 8 | Czasami (5–29%) | W 1 chorobie |
| IRAK1interleukin 1 receptor associated kinase 1 | Czasami (5–29%) | W 1 chorobie |
| KIF20Akinesin family member 20A | Czasami (5–29%) | W 1 chorobie |
| KITKIT proto-oncogene, receptor tyrosine kinase | Czasami (5–29%) | W 1 chorobie |
| LRP5LDL receptor related protein 5 | Czasami (5–29%) | W 1 chorobie |
| MLXMAX dimerization protein MLX | Czasami (5–29%) | W 1 chorobie |
| MRPL3mitochondrial ribosomal protein L3 | Czasami (5–29%) | W 1 chorobie |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Czasami (5–29%) | W 1 chorobie |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Czasami (5–29%) | W 1 chorobie |
| MT-ND2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 | Czasami (5–29%) | W 1 chorobie |
| MT-ND3mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 | Czasami (5–29%) | W 1 chorobie |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Czasami (5–29%) | W 1 chorobie |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Czasami (5–29%) | W 1 chorobie |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Czasami (5–29%) | W 1 chorobie |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Czasami (5–29%) | W 1 chorobie |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Czasami (5–29%) | W 1 chorobie |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Czasami (5–29%) | W 1 chorobie |
| MYH6myosin heavy chain 6 | Czasami (5–29%) | W 1 chorobie |
| MYH7myosin heavy chain 7 | Czasami (5–29%) | W 1 chorobie |
| MYL2myosin light chain 2 | Czasami (5–29%) | W 1 chorobie |
| MYOZ2myozenin 2 | Czasami (5–29%) | W 1 chorobie |
| MYPNmyopalladin | Czasami (5–29%) | W 1 chorobie |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Czasami (5–29%) | W 1 chorobie |
| NOD2nucleotide binding oligomerization domain containing 2 | Czasami (5–29%) | W 1 chorobie |
| PKP2plakophilin 2 | Czasami (5–29%) | W 1 chorobie |
| PNKDPNKD metallo-beta-lactamase domain containing | Czasami (5–29%) | W 1 chorobie |
| POMT1protein O-mannosyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| PRKCSHPRKCSH beta subunit of glucosidase II | Czasami (5–29%) | W 2 chorobach |
| PRRT2proline rich transmembrane protein 2 | Czasami (5–29%) | W 1 chorobie |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Czasami (5–29%) | W 1 chorobie |
| SEC63SEC63 protein translocation regulator | Czasami (5–29%) | W 1 chorobie |
| SERPINA1serpin family A member 1 | Czasami (5–29%) | W 1 chorobie |
| SLC2A10solute carrier family 2 member 10 | Czasami (5–29%) | W 1 chorobie |
| SMC5structural maintenance of chromosomes 5 | Czasami (5–29%) | W 1 chorobie |
| SPP1secreted phosphoprotein 1 | Czasami (5–29%) | W 1 chorobie |
| STAT4signal transducer and activator of transcription 4 | Czasami (5–29%) | W 1 chorobie |
| STX16syntaxin 16 | Czasami (5–29%) | W 1 chorobie |
| TBX20T-box transcription factor 20 | Czasami (5–29%) | W 1 chorobie |
| TBX4T-box transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| TERCtelomerase RNA component | Czasami (5–29%) | W 2 chorobach |
| TET2tet methylcytosine dioxygenase 2 | Czasami (5–29%) | W 1 chorobie |
| TFGtrafficking from ER to golgi regulator | Czasami (5–29%) | W 1 chorobie |
| TINF2TERF1 interacting nuclear factor 2 | Czasami (5–29%) | W 1 chorobie |
| TLL1tolloid like 1 | Czasami (5–29%) | W 2 chorobach |
| TNNC1troponin C1, slow skeletal and cardiac type | Czasami (5–29%) | W 1 chorobie |
| TNNI3troponin I3, cardiac type | Czasami (5–29%) | W 1 chorobie |
| TNNT2troponin T2, cardiac type | Czasami (5–29%) | W 2 chorobach |
| TRIM63tripartite motif containing 63 | Czasami (5–29%) | W 1 chorobie |
| BRCA2BRCA2 DNA repair associated | Rzadko (1–4%) | W 1 chorobie |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Rzadko (1–4%) | W 1 chorobie |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Rzadko (1–4%) | W 1 chorobie |
| FLNAfilamin A | Rzadko (1–4%) | W 1 chorobie |
| GPC3glypican 3 | Rzadko (1–4%) | W 1 chorobie |
| H19H19 imprinted maternally expressed transcript | Rzadko (1–4%) | W 1 chorobie |
| POU6F2POU class 6 homeobox 2 | Rzadko (1–4%) | W 1 chorobie |
| RESTRE1 silencing transcription factor | Rzadko (1–4%) | W 1 chorobie |
| TRIM28tripartite motif containing 28 | Rzadko (1–4%) | W 1 chorobie |
| TRIP13thyroid hormone receptor interactor 13 | Rzadko (1–4%) | W 1 chorobie |
| WT1WT1 transcription factor | Rzadko (1–4%) | W 1 chorobie |
| ABCA3ATP binding cassette subfamily A member 3 | Nie odnotowano | W 1 chorobie |
| ACVRL1activin A receptor like type 1 | Nie odnotowano | W 1 chorobie |
| ARXaristaless related homeobox | Nie odnotowano | W 1 chorobie |
| CASRcalcium sensing receptor | Nie odnotowano | W 1 chorobie |
| CRLF1cytokine receptor like factor 1 | Nie odnotowano | W 1 chorobie |
| CSPP1centrosome and spindle pole associated protein 1 | Nie odnotowano | W 1 chorobie |
| ISCUiron-sulfur cluster assembly enzyme | Nie odnotowano | W 1 chorobie |
| LTBP3latent transforming growth factor beta binding protein 3 | Nie odnotowano | W 1 chorobie |
| MUC5Bmucin 5B, oligomeric mucus/gel-forming | Nie odnotowano | W 1 chorobie |
| MYBPC3myosin binding protein C3 | Nie odnotowano | W 1 chorobie |
| SFTPA2surfactant protein A2 | Nie odnotowano | W 1 chorobie |
| SFTPBsurfactant protein B | Nie odnotowano | W 1 chorobie |
| SLC25A1solute carrier family 25 member 1 | Nie odnotowano | W 1 chorobie |
| SLC52A3solute carrier family 52 member 3 | Nie odnotowano | W 1 chorobie |
| SMPD1sphingomyelin phosphodiesterase 1 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni